Novel cyclic naphthalene diimide dimer with strengthened ability to stabilize dimeric G-quadruplex by Takeuchi  Ryusuke et al.
Cyclic Naphthalene Diimide Dimer with a
Strengthened Ability to Stabilize Dimeric G‐
Quadruplex
著者 Takeuchi  Ryusuke, Zou  Tingting, Wakahara 









その他のタイトル Novel cyclic naphthalene diimide dimer with









Novel cyclic naphthalene diimide dimer with strengthened ability 
to stabilize dimeric G-quadruplex 
Ryusuke Takeuchi,a Tingting Zou,ab Daiki Wakahara,a Yoshifumi Nakano,a Shinobu Sato,ab Shigeori 
Takenaka ab* 
Abstract: New type of dimeric cyclic naphthalene diimide derivatives 
(cNDI-dimers) carrying varied linker length were designed and 
synthesized to recognize dimeric G-quadruplex structures. All of the 
cNDI-dimers exhibited high preference to recognize G-quadruplex 
structures, and significant enhanced the thermal stability of dimeric G-
quadruplex structure than cNDI monomer with increasing melting 
temperature by more than 23 ºC, which indicated the strengthened 
ability of cNDI dimers for stabilizing dimeric G-quadruplex. cNDI 
dimers also performed stronger ability to inhibit telomerase activity 
and stop telomere DNA elongation than cNDI monomer, which 
showed an improved anti-cancer potentiality for further therapeutic 
application. 
Telomerase was thought to be essential for the 
immortalization of human cells, for its function in restoring 
telomeric DNA sequences[1].  It has been reported that 
telomerase was up-regulated in 85% of human cancer 
cells[2,3], and its mutant with complete-activity inhibition could 
lead to the death of tumour cells[4]. Besides, telomerase is 
generally not expressed in most normal human cells. These 
critical features lead to the rapid development of telomerase 
-targeted cancer therapies in advanced clinical trials[5–7]. 
Over past two decades, four stranded G-quadruplex 
nucleic acid structure is of great interest as a potential 
therapeutic target[8,9], for the important roles it played in 
regulating gene expression and even translation[10]. It also 
has been proved that G-quadruplex structures formed in G-
rich telomeric DNA can inhibit telomerase activity[11–13]. For 
this reason, it’s considered as a promising therapeutic path 
to develop small molecules, working as G4 ligands, to 
selectively stabilize human telomeric DNA with four stranded 
G-quadruplex structures, further enhance the inhibition of 
telomerase activity and induce cancer cell death[14]. Besides, 
some reports already suggested that G-quadruplex structure 
in telomeric sequence assembled like beads on a string[15,16], 
G4 ligands which can selectively target multiple G4 repeats 
might be promising for further enhanced specificity on 
inhibiting telomerase function, and are attracting more 
attention of G-quadruplex researchers. These several years, 
some ligand-dimers[17-24] and tetramer[25] have been reported 
with strong ability to recognize dimeric or multiple G-
quadruplex structures, which supported that G4 ligand-
multimer might be a good model for stabilizing G-quadruplex 
repeats. 
As one important G4 ligand, naphthalene diimide can 
recognize G-quadruplex structure through π-π stacking[26], 
and its binding affinity to G-quadruplex was rarely affected 
even under in vivo mimic molecular crowding condition and 
may represent superior telomerase inhibitors in cell 
nuclei[27,28]. Our group has been working on designing novel 
G4 ligands with improved specificity for recognizing G-
quadruplex[29-31], and previously we reported cyclic 
naphthalene diimide coupling with cyclohexane (cNDI-ch), 
which exhibited significant higher affinity (260-fold) towards 
binding with G-quadruplex than double strand DNA[29]. 
Besides, Chiara Marchetti et al also reported similar 
macrocyclic naphthalene diimides coupling with phenyl ring, 
which exhibited high selectivity for G-quadruplex structure 
and showed anti-proliferative effects on cancer line with low 
range of concentrations [32]. Here in this study, we report a 
group of cNDI-dimers by linking two cNDI monomers with 
alkyl chain, and these cNDI-dimers could recognize dimeric 
G-quadruplex structure and show enhanced ability to 
stabilize G-quadruplex structures.  
Based on our previous reports[29], cNDI coupling with glutamine 
acid was synthesized as a cNDI-monomer, which contains a free 
amino group, and enable higher flexibility for constructing new 
derivatives. Then two cNDI monomers (1) was linked by different 
length of alkyl chain (n=3, 5 or 7) to obtain a group of cNDI dimers 
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Figure 1. Chemical structures of monomeric cNDI (1), cNDI-
dimers (2-4) with varied linker chain (n=3, 5, or 7) and cNDI 
modified acyl group (5). 





(2-4, Fig. 1). To avoid the influence of free amino group when 
comparing the performance of cNDI-dimers and cNDI-monomer, 
in this research, the free amino group was protected by acyl group, 
and the obtained cNDI-Ac (5) was adopted as the monomer 
control (Fig. 1). The synthesis process and chemical confirmation 
of 2-5 was detailed clarified in the supplementary information.  
Two telomeric sequences, G1, 5'-TA(GGGTTA)3-GGG-3', and 
G2T1, 5'-A(TTAGGG)8-3', were adopted as G-quadruplex model, 
which contained one hybrid G4 structure, and two G4 units 
respectively[25]. Within the presence of K+, G-quadruplex 
structures were prepared by a slow-cool down annealing process. 
Under circular dichroism (CD) spectra measurement, a typical 
spectrum of hybrid G4 structure with a negative band at 240 nm 
and a positive band at 290 nm (Fig. 2 and Fig. S10) was verified. 
Similarly to previous reported NDI derivatives[33,34], as titrating 2-
4 or 5 to G1, the clear intensity shifting of negative band at 240 
nm (weakened) and positive bands at 290 nm (enhanced) were 
observed, which revealed the G4 structures could be recognized 
by these cNDI derivatives. As titrating 2-4 or 5 to G2T1, 
decreased negative bands were observed for all ligands, but 
comparing to 5, all three cNDI-dimers showed more obvious 
enhanced positive band (Fig. 2D), which supported that cNDI-
dimers preferred a stronger ability to recognize dimeric G-
quadruplex structures. To be mentioned, adding cNDI-dimer to 
G1 induced slightly right shift of the negative band (Fig. 2B), which 
might suggest that the free naphthalene diimide skeleton of cNDI-
dimers may interact with G-quadruplex and induce some structure 
change.  
To evaluate the binding affinity of ligands towards G4 structure, 
we employed Isothermal Titration Calorimetry (ITC) for 
determination. As a powerful technique, ITC can provide the 
binding affinity of ligand to G-quadruplex, and also help elucidate 
the thermodynamic change during recognition[35,36]. The binding 
affinities of 2-4 and 5 towards G-quadruplex DNA (G1, G2T1) and 
double-strand DNA (HP27 oligo sequence, 5'- 
GCGATTCTCGGCTTTGCCGAGAATCGC-3') were investigated. 
According to the results (Table 1, Fig. S11-12), 2-4 and 5 showed 
similarly high affinity towards binding to single G-quadruplex (over 
2×106 M-1), and cNDI-dimers’ affinity were slightly higher than 5. 
However, when towards recognizing dimeric G-quadruplexes, 2-
4 exhibited decreased binding affinity (around 3×105 M-1), and 
lower than that of 5 towards dimeric G-quadruplex. One 
considerable reason was that higher ΔS of 2-4 binding with 
dimeric intramolecular G-quadruplex (resulting higher ΔG) may 
partly reflect inherent differences in hydration for DNA structure 
and/or binding–induced release of counterions [37,38]. And another 
possible reason was that the bigger structure of cNDI-dimer may 
decrease its accessibility to dimeric G-quadruplex [39]. Although 3 
showed slight stronger affinity towards G-quadruplex than 2 and 
4, the difference was not significant. Besides, for both 2-4 and 5, 
the energy changes towards recognizing HP27 were quite small, 
and no clear binding affinity fitting curve could be obtained, which 
further indicated the enhanced ability of cNDI derivatives to 
discriminate G-quadruplex and duplex DNA (Fig. S13).  
When comparing the thermodynamic parameter changes, 2-4 
and 5 binding to G-quadruplex structures were exothermic, but 2-
4 induced larger negative ΔH and ΔS values than 5, which 
suggested that cNDI-dimer-G-quadruplex complex was more 
stable than cNDI-Ac-G-quadruplex complex.  UV-Vis was also 
adopted for confirming the binding performance of these cNDI 
derivatives (Fig. S14). When titrating annealed G1 or G2T1 
sequence to 2 or 5, large hypochromic, small red shifts and a 
single isosbestic point were obtained at 390 nm for all titrations, 
suggesting the stacking interaction between naphthalene diimide 






2 3 4 5 
 
2 3 4 5 
Ka / 10
5 M-1  41.9±0.8 44.9±2.0 38.6±1.3 21.2±0.1 
 
2.80±0.01 3.8±0.02 3.1 ±0.00 17.2±0.1 
n   1 1 1 2 
 
1 1 1 3 
ΔH / kcal mol-1 -11.8±0.06 -13.4±0.1 -13.8±0.2 -7.7±0.50 
 
-11.3±0.07 -11.5±0.2 -11.4±0.2 -8.7±0.04 
-TΔS / kcal mol-1 2.76±0.07 4.31±0.11 4.79±0.09 -0.92±0.54 
 
3.88±0.18 3.88±0.22 3.93±0.06 0.06±0.04 
ΔS / cal mol-1 K-1 -9.25±0.25 -14.5±0.38 -16.1±0.31 3.08±1.81  -13.0±0.59 -13.0±0.73 -13.2±0.22 -0.19±0.14 
ΔG / kcal mol-1  -9.0±0.2 -9.1±0.03 -9.0±0.03 -8.6±0.04 
 
-7.4±0.01 -7.6±0.02 -7.5±0.04 -8.5±0.01 
Condition: 50 mM Potassium phosphate buffer (pH 7.0), 25ºC. 
 
Figure 2. CD spectra analysis. G1 (1.5 μM) with the presence of varying 
equivalents of 3 (A), and 5 (B); G2T1 (1.5 μM) with the presence of 3 (C), 
and 5 (D). Buffer: 50 mM Tris-HCl (pH 7.4) and 100 mM KCl. Ligand vs. 












































































































































































skeleton and G-quartet planes as a main driving force in their 
interaction, and formed a unified G-quadruplex-ligand complex 
structure.  
After adding cNDI derivatives, the melting temperature change 
(ΔTm) was calculated, which represent the ability of cNDI 
derivatives for stabilizing G-quadruplex structure. For HP27, 
almost no enhancement were observed for both cNDI-Ac and 
cNDI-dimers (Fig. S15). As adding 5 to G1 in 2:1 ratio, Tm 
increased by 8.9 ºC, which is similar to the case of 2-4 to G1 in 
1:1 ratio (Tm was increased by 9.7-10.4 ºC) (Fig. 3A and 3C, Fig 
S16). As previously mentioned, when 2-4 recognizing the single 
G-quadruplex, one naphthalene diimide skeleton stacked to G-
quartet, another free naphthalene diimide might form some 
interaction with G-quadruplex structure, and further enhance the 
stabilization, which also might be correlated with the observed CD 
spectra shift. However, 5 showed much weaker ability to stabilize 
G2T1 structure in 1:1 ratio with increasing the Tm only by 2.7±0.6 
ºC, and continuing adding 5 to G2T1 to 2:1 ratio, Tm was increased 
by 8.8±1.1 ºC (Tm was 59.9 ºC). While, when adding cNDI-dimers 
to G2T1 in 1:1 ratio, Tm increased by 15.7-16.1 ºC (enhanced to 
67.0-67.4 ºC), which is even much higher than adding 5 in 2:1 
ratio. These results also suggested that cNDI-dimer-G-
quadruplex complex was more stable, which was in consistent 
with the thermodynamic parameters obtained by ITC, and further 
confirmed the stronger ability of 2-4 for stabilizing dimeric G-
quadruplex structure (Fig. 3B and 3D, Fig. S16). Regarding the 
possible binding models, when adding 5 to G2T1 in 2:1 ratio, 
naphthalene diimide skeletons may stabilize single G-quadruplex 
structure or two G-quadruplex structures, as for 2-4, the 
preference for recognizing the dimeric G-quadruplex structure 
strengthened their ability to enhance the thermal stability of G2T1. 
G4 structures were significantly stabilized when adding cNDI-
dimers to G2T1 in 2:1 ratio (Tm increased by 21.7-22.2 ºC), which 
further convinced the high ability of cNDI-dimers for stabilizing G-
quadruplex structure, continuously adding 2-4 didn’t further 
increase the melting temperature supported that cNDI-dimers’ 
preference for simultaneously recognizing two G4 units (Fig. 3, 
Fig S16). In our report, no significant difference of optimized linker 
length was observed, this might because that the length of cyclic 
shape plus alkyl chain linker could cover the distance for 
recognizing dimeric G-quadruplex. 
 To investigate the ability of 2-5 for inhibiting telomerase activity, 
instead of using general PCR coupling with gel shift TRAP assay, 
here we adopted an PCR-free telomerase assay using 
chronocoulometry coupled with hexaammineruthenium(III) 
chloride developed by our group, to conduct the evaluation[29,40]. 
The results (Fig. 4) indicated that, without adding G4 ligand, 
telomere DNA can be elongated by telomerase to (TTAGGG)14.2, 
while with adding 5 (12.5 nM) to DNA (20 nM), telomere DNA 
elongation stopped at (TTAGGG)13.2, continuously adding 5 to 25 
nM, DNA elongation was stopped at  (TTAGGG)12.6, while, with 
adding 12.5 nM of 2, telomere DNA could only be elongated to 
(TTAGGG)9.0 (Fig. 4 and Fig. S17), and obtained shorter telomere 














































































































Ligand vs G2T1 1:1 2:1 3:1
Figure 3. Melting curves of 1.5 μM G1 (A), and 1.5 μM G2T1 (B) with the presence of varying equivalents of 3 (left), and 5 (right); ΔTm plot of G1 (C), and  G2T1 
(D) in the presence of varying equivalents of 2-5. Buffer: 50 mM Tris-HCl (pH 7.4) and 30 mM KCl. Ligand vs. DNA; 0:1 (Red); 1:1 (Blue); 2:1 (Orange); 3:1 
(Green).  
Figure 4. Telomere DNA elongation by telomerase was inhibited by 2 or 5. 





enhanced ability to inhibit telomerase ability than monomeric 
cNDI. 
Conclusion 
In this study, we designed and synthesized new cNDI derivatives, 
termed as cNDI-dimers for targeting dimeric G-quadruplex. cNDI-
dimers exhibited higher preference for recognizing and stabilizing 
dimeric G-quadruplex structures than monomeric cNDI, and 
further possessed an enhanced ability to inhibit telomerase 
activity, which improved cNDI’s potentiality as a promising 
telomerase inhibitor for further anti-cancer application. 
Experimental section 
Details list in the supplementary information. 
Acknowledgements 
This work was supported in part by Ministry of Education, 
Culture, Sports, Science, and Technology (MEXT), Japan. 
Key words:  G-quadruplex • cyclic naphthalene diimide • dimer 
• stability 
[1] T. M. Bryan, A. Englezou, L. Dalla-Pozza, M. A. Dunham, R. 
R. Reddel, Nat. Med. 1997, 3, 1271–1274. 
[2] R. H. Vonderheide, Oncogene 2002, 21, 674–679. 
[3] J. W. Shay, S. Bacchetti, Eur. J. Cancer Part A 1997, 33, 
787–791. 
[4] W. C. Hahn, S. A. Stewart, M. W. Brooks, S. G. York, E. 
Eaton, A. Kurachi, R. L. Beijersbergen, J. H. M. Knoll, M. 
Meyerson, R. A. Weinberg, Nat. Med. 1999, 5, 1164–1170. 
[5] C. B. Harley, Nat. Rev. Cancer 2008, 8, 167–179. 
[6] A. Ahmed, T. Tollefsbol, J. Am. Geriatr. Soc. 2003, 51, 116–
122. 
[7] P. Cunningham, W. K. Love, R. W. Zhang, L. G. Andrews, T. 
O. Tollefsbol, Curr. Med. Chem. 2006, 13, 2875–2888. 
[8] S. Neidle, M. A. Read, Biopolymers 2000, 56, 195–208. 
[9] S. Kerwin, Curr. Pharm. Des. 2005, 6, 441–471. 
[10] R. Hänsel-Hertsch, D. Beraldi, S. V. Lensing, G. Marsico, K. 
Zyner, A. Parry, M. Di Antonio, J. Pike, H. Kimura, M. Narita, 
et al., Nat. Genet. 2016, 48, 1267–1272. 
[11] D. Sun, B. Thompson, B. E. Cathers, M. Salazar, S. M. 
Kerwin, J. O. Trent, T. C. Jenkins, S. Neidle, L. H. Hurley, J. 
Med. Chem. 1997, 40, 2113–2116. 
[12] C. Y. Chen, Q. Wang, J. Q. Liu, Y. H. Hao, Z. Tan, J. Am. 
Chem. Soc. 2011, 133, 15036–15044. 
[13] Y. Xu, Chem. Soc. Rev. 2011, 40, 2719–2740. 
[14] S. Asamitsu, S. Obata, Z. Yu, T. Bando, H. Sugiyama, 
Molecules 2019, 24, 429. 
[15] H. Yu, X. Gu, S. I. Nakano, D. Miyoshi, N. Sugimoto, J. Am. 
Chem. Soc. 2012, 134, 20060–20069. 
[16] J. Abraham Punnoose, Y. Cui, D. Koirala, P. M. Yangyuoru, 
C. Ghimire, P. Shrestha, H. Mao, J. Am. Chem. Soc. 2014, 
136, 18062–18069. 
[17]       K. Iida, S. Majima, T. Nakamura, H. Seimiya, K. Nagasawa. 
Molecules 2013, 18, 4328-4341. 
[18]       C. Zhao, L. Wu, J. Ren, Y. Xu, X. Qu. J. Am. Chem. Soc. 
2013, 135, 18786−1878. 
[19]        M. Tera, T. Hirokawa, S. Okabe, K. Sugahara, H. Seimiya, 
K. Shimamoto. Chem. Eur.J. 2015, 21,14519 –14528. 
[20]         C. Zhou, J. Yang, C. Dong, Y. Wang, B. Sun, J. Chen, Y. Xu, 
W. Chen. Org. Biomol. Chem.,2016, 14,191–197 
[21]        C. Zhou, T. Liao, Z. Li, J. Gonzalez-Gercia, M. Reynolds, M. 
Zou, R. Vilar. Chem. Eur.J. 2017, 23,4713 –4722. 
[22]      T. Liao, T. Ma, Z. Liang, X. Zhang, C. Luo, L. Liu, C. Zhou. 
Chem. Eur. J. 2018, 24, 15840–15851. 
[23]      C. Zhou, Z. Li, T. Liao, T. Ma, S. Chen, Y. Liang. RSC Adv. 
2018, 8, 23257–23261 
[24]        I. P. Hwang, P. Mailliet, V. Hossard, J. F. Riou, A. Bugaut, L. 
Roger. Molecules 2019, 24, 577 
[25]     J. A. Punnoose, Y. Ma, Y. Li, M. Sakuma, S. Mandal, K. 
Nagasawa, H. Mao. J. Am. Chem. Soc. 2017, 139, 7476-
7484. 
[26] G. W. Collie, R. Promontorio, S. M. Hampel, M. Micco, S. 
Neidle, G. N. Parkinson, J. Am. Chem. Soc. 2012, 134, 
2723–2731. 
[27] M. Arévalo-Ruiz, F. Doria, E. Belmonte-Reche, A. De Rache, 
J. Campos-Salinas, R. Lucas, E. Falomir, M. Carda, J. M. 
Pérez-Victoria, J. L. Mergny, M. Freccero, J. C. Morales. 
Chem. Eur. J. 2017, 23, 2157–2164. 
[28] H. Yaku, T. Murashima, H. Tateishi-Karimata, S. ichi Nakano, 
D. Miyoshi, N. Sugimoto, Methods 2013, 64, 19–27. 
[29] Y. Esaki, M. M. Islam, S. Fujii, S. Sato, S. Takenaka, Chem. 
Commun. 2014, 50, 5967–5969. 
[30] M. M. Islam, S. Fujii, S. Sato, T. Okauchi, S. Takenaka, 
Molecules 2015, 20, 10963–10979. 
[31] M. M. Islam, S. Sato, S. Shinozaki, S. Takenaka, Bioorganic 
Med. Chem. Lett. 2017, 27, 329–335. 
[32]        C. Marchetti, A. Minarini, V. Tumiatti, F. Moraca, L. Parrotta, 
S. Alcaro, R. Rigo, C. Sissi, M. Gunaratnam, S. A. Ohnmacht, 
S. Neidle, A. Milelli, Bioorg. Med. Chem. 2015, 23, 3819-
3830. 
[33] L. Germani, C. Percivalle, M. Palumbo, M. Freccero, S. N. 
Richter, F. Doria, G. Sattin, M. Nadai, M. Di Antonio, 
Biochimie 2011, 93, 1328–1340. 
[34] S. T. G. Street, D. N. Chin, G. J. Hollingworth, M. Berry, J. C. 
Morales, M. C. Galan, Chem. Eur. J. 2017, 23, 6953–6958. 
[35] I. Haq, J. O. Trent, B. Z. Chowdhry, T. C. Jenkins, J. Am. 
Chem. Soc. 2011, 121, 1768–1779. 
[36] B. Pagano, C. A. Mattia, C. Giancola, Int. J. Mol. Sci. 2009, 
10, 2935–2957. 
[37] I. Haq, J. O. Trent, B. Z. Chowdhry, T. C. Jenkins, J. Am. 
Chem. Soc. 1999, 121, 1768-1779 
[38] P. J. Perry, A. P. Reszka, A. A. Wood, M. A. Read, S. M. 
Gowan, H. S. Dosanjh, J. O. Trent, T. C. Jenkins, L. R. 
Kelland, S. Neidle, J. Med. Chem. 1998, 41, 4873-4884. 
[39] Y. Kawamoto, A. Sasaki, A. Chandran, K. Hashiya, S. Ide, T. 
Bando, K. Maeshima, H. Sugiyama, J. Am. Chem. Soc. 2016, 
138, 14100–14107. 
[40] S. Sato, S. Takenaka, Anal. Chem. 2012, 84, 1772–1775. 












New type of dimeric cyclic naphthalene 
diimide derivatives (cNDI-dimers) 
carrying varied linker length exhibited 
high preference to recognize G-
quadruplex structures, and significant 
enhanced the thermal stability of 
dimeric G-quadruplex structure 
   Ryusuke Takeuchi, a Tingting Zou,ab 
Daiki Wakahara,a Yoshifumi Nakano,a 
Shinobu Sato,ab Shigeori Takenaka ab* 
Page No. – Page No. 
 
Novel cyclic naphthalene diimide 
dimer with strengthened ability to 
stabilize dimeric G-quadruplex 
  
 
